MeSH term
Frequency | Condition_Probility | Comparative Study | 17 | 0.0 |
*Gene Expression Profiling | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Humans | 82 | 0.0 |
Immunohistochemistry | 12 | 0.0 |
Oligonucleotide Array Sequence Analysis | 7 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 58 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Animals | 22 | 0.0 |
Cells, Cultured | 15 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Adult | 19 | 0.0 |
Female | 31 | 0.0 |
Male | 31 | 0.0 |
Matrix Metalloproteinases/genetics/*metabolism | 2 | 25.0 |
Middle Aged | 21 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Tissue Inhibitor of Metalloproteinases/genetics/*metabolism | 2 | 33.0 |
*Chromosome Mapping | 2 | 0.0 |
*X Chromosome | 2 | 0.0 |
Alleles | 3 | 0.0 |
Cell Line | 4 | 0.0 |
*Dosage Compensation (Genetics) | 2 | 1.0 |
Gene Expression | 3 | 0.0 |
Hybrid Cells | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/*genetics | 6 | 37.0 |
Aged | 16 | 0.0 |
Biological Markers/analysis | 2 | 0.0 |
Cell Division | 7 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 6 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Tissue Donors | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/metabolism | 6 | 21.0 |
DNA/metabolism | 2 | 0.0 |
English Abstract | 7 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
RNA, Messenger/analysis | 7 | 0.0 |
DNA Primers/chemistry | 4 | 0.0 |
Gene Transfer Techniques | 2 | 0.0 |
Mice | 12 | 0.0 |
Mice, Nude | 5 | 0.0 |
Neoplasm Invasiveness | 8 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/*genetics | 2 | 28.0 |
Cluster Analysis | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Collagen/biosynthesis/genetics | 2 | 12.0 |
Fibrosis | 2 | 1.0 |
Gene Library | 2 | 0.0 |
Proteoglycans/biosynthesis/genetics | 2 | 25.0 |
Stromal Cells/metabolism/pathology | 2 | 4.0 |
Fibroblasts | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/biosynthesis | 4 | 26.0 |
Disease Progression | 4 | 0.0 |
Gene Expression Profiling | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Prognosis | 5 | 0.0 |
Survival Analysis | 2 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Cell Movement | 3 | 0.0 |
Culture Media, Serum-Free/pharmacology | 2 | 1.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Fibroblasts/*metabolism | 2 | 1.0 |
Immunoblotting | 3 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
*Neovascularization, Physiologic | 2 | 1.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Time Factors | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Mutation | 2 | 0.0 |
Matrix Metalloproteinases/*analysis | 2 | 28.0 |
Tissue Inhibitor of Metalloproteinases/*analysis | 2 | 100.0 |
Aged, 80 and over | 7 | 0.0 |
Collagen/metabolism | 2 | 0.0 |
Matrix Metalloproteinases/biosynthesis | 2 | 33.0 |
Receptors, Collagen | 2 | 2.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
Neoplasm Proteins/*metabolism | 3 | 0.0 |
Neoplasm Staging | 4 | 0.0 |
Survival Rate | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/analysis | 2 | 22.0 |
Gene Expression Regulation | 2 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/*blood | 2 | 25.0 |
Reference Values | 3 | 0.0 |
Base Sequence | 8 | 0.0 |
Enzyme Activation | 4 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Gelatinase A/*metabolism | 2 | 6.0 |
Gelatinase B/*metabolism | 2 | 6.0 |
Pregnancy | 3 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/metabolism | 2 | 9.0 |
Tissue Inhibitor of Metalloproteinases/*metabolism | 2 | 33.0 |
Gelatinase A | 9 | 12.0 |
Interstitial Collagenase | 7 | 16.0 |
Blotting, Northern | 6 | 0.0 |
Metalloendopeptidases/*metabolism | 4 | 4.0 |
Rats | 4 | 0.0 |
Rats, Wistar | 2 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Metalloendopeptidases/metabolism | 3 | 4.0 |
Gelatinase B | 9 | 11.0 |
Blotting, Western | 3 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Interleukin-1/*pharmacology | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/biosynthesis/genetics | 2 | 25.0 |
*Extracellular Matrix Proteins | 2 | 1.0 |
*Proteoglycans | 2 | 10.0 |
Cloning, Molecular | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinases/*genetics | 2 | 50.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Collagenases/metabolism | 2 | 5.0 |
Enzyme Precursors/metabolism | 2 | 1.0 |
Gelatin/metabolism | 2 | 14.0 |
Gelatinases/*metabolism | 2 | 8.0 |
Protein Binding | 3 | 0.0 |
Skin/blood supply | 2 | 3.0 |
In Situ Hybridization | 4 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2 | 6 | 21.0 |
Tissue Inhibitor of Metalloproteinases | 13 | 20.0 |
Organ Culture Techniques | 3 | 0.0 |
Organ Specificity | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Transfection | 2 | 0.0 |
Stromelysin 1 | 5 | 13.0 |
Collagenases/genetics | 2 | 10.0 |
Glycoproteins/*biosynthesis/genetics | 3 | 20.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Gelatinases/metabolism | 2 | 6.0 |
Neoplasm Transplantation | 3 | 0.0 |
*Protein Biosynthesis | 3 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Adolescent | 4 | 0.0 |
Culture Media | 2 | 0.0 |
Glycoproteins/metabolism | 2 | 1.0 |
In Vitro | 2 | 0.0 |
Extracellular Matrix/*enzymology | 3 | 23.0 |
Tissue Inhibitor of Metalloproteinase-1/*biosynthesis/genetics | 2 | 66.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
